Brooks Laboratories Limited — Board Meeting, 13-02-2025: Outcome of Board Meeting

The Board of Directors of Brooks Laboratories Limited has announced a board meeting on February 13, 2025, during which they approved the unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2024. Total income for the consolidated period was ₹59.50 crore, with expenses of ₹57.82 crore, resulting in a net profit of ₹1.68 crore. The Company also reported an ongoing investment in its joint venture, Brooks Steriscience Limited. This aligns with its strategic expansion efforts in the pharmaceutical sector.